These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2163060)

  • 41. 3H-Imipramine binding sites in platelets of hospitalized psychiatric patients.
    Gentsch C; Lichtsteiner M; Gastpar M; Gastpar G; Feer H
    Psychiatry Res; 1985 Mar; 14(3):177-87. PubMed ID: 2988002
    [TBL] [Abstract][Full Text] [Related]  

  • 42. 2-nitroimipramine: a selective irreversible inhibitor of [3H] serotonin uptake and [3H] imipramine binding in platelets.
    Rehavi M; Ittah Y; Rice KC; Skolnick P; Goodwin FK; Paul SM
    Biochem Biophys Res Commun; 1981 Apr; 99(3):954-9. PubMed ID: 7247951
    [No Abstract]   [Full Text] [Related]  

  • 43. Altered platelet 3H-imipramine binding in schizo-affective and depressive disorders.
    Suranyi-Cadotte BE; Wood PL; Schwartz G; Nair NP
    Biol Psychiatry; 1983 Aug; 18(8):923-7. PubMed ID: 6311293
    [No Abstract]   [Full Text] [Related]  

  • 44. No correlation between platelet imipramine binding and CSF 5HIAA in neurosurgical patients.
    Stoff DM; Goldman W; Bridger WH; Jain AK; Pylypiw A
    Psychiatry Res; 1990 Sep; 33(3):323-6. PubMed ID: 1700859
    [No Abstract]   [Full Text] [Related]  

  • 45. Platelet 3H-imipramine binding and red blood cell choline in affective disorders: indications of heterogeneous pathogenesis.
    Wood PL; Suranyi-Cadotte B; Schwartz G; Nair NP
    Biol Psychiatry; 1983 Jun; 18(6):715-9. PubMed ID: 6307404
    [No Abstract]   [Full Text] [Related]  

  • 46. [3H]-imipramine binding sites in fawn-hooded rats.
    Murray TF; DeBarrows BR; Prieur DJ; Meyers KM
    Neuropharmacology; 1983 Jun; 22(6):781-4. PubMed ID: 6310435
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Platelet [3H]imipramine binding in depressed patients and its circadian variations in healthy controls.
    Nankai M; Yoshimoto S; Narita K; Takahashi R
    J Affect Disord; 1986; 11(3):207-12. PubMed ID: 3031144
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Plasma of depressed patients enhances platelet imipramine binding.
    Marazziti D; Rotondo A; Perugi G; Placidi GF; Cassano GB; Pacifici GM
    Biol Psychiatry; 1989 Apr; 25(7):985-7. PubMed ID: 2541806
    [No Abstract]   [Full Text] [Related]  

  • 49. Reduction of (3H)-imipramine binding sites on platelets of conduct-disordered children.
    Stoff DM; Pollock L; Vitiello B; Behar D; Bridger WH
    Neuropsychopharmacology; 1987 Dec; 1(1):55-62. PubMed ID: 2855302
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Significant correlation between 14C-5-HT uptake by and 3H-paroxetine binding to platelets from healthy volunteers.
    Maguire K; Tuckwell V; Pereira A; Dean B; Singh B
    Biol Psychiatry; 1993 Sep; 34(6):356-60. PubMed ID: 8218602
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of filtration and equilibrium dialysis methods for [3H]imipramine binding to human platelets.
    Lui N; Almon RR; Jusko WJ
    Anal Biochem; 1984 May; 139(1):42-57. PubMed ID: 6331229
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Decreased platelet 3H-imipramine binding in Down's syndrome.
    Tang SW; Berg JM; Bruni J; Davis A
    Psychiatry Res; 1988 Apr; 24(1):67-70. PubMed ID: 2839861
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Blood platelets in psychopharmacological research.
    Rotman A
    Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(2-3):135-51. PubMed ID: 6310688
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Reduced inhibitory effect of imipramine on radiolabeled serotonin uptake into platelets in geriatric depression.
    Slotkin TA; Whitmore WL; Barnes GA; Krishnan KR; Blazer DG; Knight DL; Nemeroff CB
    Biol Psychiatry; 1989 Mar; 25(6):687-91. PubMed ID: 2538161
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Differences between sodium-dependent and desipramine-defined [3H]imipramine binding in intact human platelets.
    Hrdina PD
    Biol Psychiatry; 1989 Mar; 25(5):576-84. PubMed ID: 2537664
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Platelet 3H-imipramine binding in bipolar patients.
    Muscettola G; Di Lauro A; Giannini CP
    Psychiatry Res; 1986 Aug; 18(4):343-53. PubMed ID: 3018819
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of protein concentration on kinetic constants (Kd and Bmax) of 3H-imipramine binding in blood platelets.
    Arora RC; Wunnicke V; Meltzer HY
    Biol Psychiatry; 1985 Jan; 20(1):116-9. PubMed ID: 2981127
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Serotonin uptake and imipramine binding in the blood platelets of obsessive-compulsive disorder patients.
    Bastani B; Arora RC; Meltzer HY
    Biol Psychiatry; 1991 Jul; 30(2):131-9. PubMed ID: 1655071
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of fluoxetine treatment of platelet 3H-imipramine binding, 5-HT uptake and 5-HT content in major depressive disorder.
    Wgner A; Montero D; Mårtensson B; Siwers B; Asberg M
    J Affect Disord; 1990 Oct; 20(2):101-13. PubMed ID: 2176228
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Relationship between seasonal patterns of platelet serotonin uptake and 3H-imipramine binding in depressed patients and normal controls.
    Chicz-DeMet A; Reist C; DeMet EM
    Prog Neuropsychopharmacol Biol Psychiatry; 1991; 15(1):25-39. PubMed ID: 2008538
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.